Order Article Reprints

Aniogo E, Williams L, Hong T, Wong P, Hui SK, Ghimire H, Poku EK, Colcher DM, Yazaki PJ, Shively JE, et al. Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors. Cancers. 2025; 17(9):1453. https://doi.org/10.3390/cancers17091453

Aniogo, Eric, Lindsay Williams, Teresa Hong, Patty Wong, Susanta K. Hui, Hemendra Ghimire, Erasmus K. Poku, David M. Colcher, Paul J. Yazaki, John E. Shively, and et al. 2025. "Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors" Cancers 17, no. 9: 1453. https://doi.org/10.3390/cancers17091453

Aniogo, E., Williams, L., Hong, T., Wong, P., Hui, S. K., Ghimire, H., Poku, E. K., Colcher, D. M., Yazaki, P. J., Shively, J. E., & Kujawski, M. (2025). Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors. Cancers, 17(9), 1453. https://doi.org/10.3390/cancers17091453